Douglas Matthew Brown - Nov 23, 2021 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role
Chief Strategy Officer
Signature
/s/ Doug M Brown
Stock symbol
NEO
Transactions as of
Nov 23, 2021
Transactions value $
-$3,696,000
Form type
4
Date filed
11/26/2021, 03:14 PM
Next filing
Dec 30, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEO Common Stock Sale -$1.24M -33.3K -29.86% $37.19 78.3K Nov 23, 2021 Direct F1
transaction NEO Common Stock Sale -$1.23M -33.3K -42.56% $36.84 45K Nov 24, 2021 Direct F1
transaction NEO Common Stock Sale -$1.23M -33.3K -74.11% $36.85 11.6K Nov 26, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NEO Stock Option (Right to Buy) 45K Nov 23, 2021 Common Stock 45K $28.33 Direct F2
holding NEO Stock Option (Right to Buy) 26.4K Nov 23, 2021 Common Stock 26.4K $53.17 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2 On March 2, 2020, Mr. Brown was granted 45,017 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F3 On March 2, 2021, Mr. Brown was granted 26,378 stock options. These options vest ratably over the first four anniversary dates of the grant date.